US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 2.6100
  • +0.0400+1.56%
Close Dec 2 16:00 ET
  • 2.6100
  • 0.00000.00%
Post 20:01 ET
2.19MMarket Cap-2718P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sonnet BioTherapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 28.500K--
--2024/Q20.000 / 12.330K--
--2024/Q118.630K / 12.000K--
--2023/Q437.260K / 18.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 28.500K--
--2024/Q20.000 / 12.330K--
--2024/Q118.630K / 12.000K--
--2023/Q437.260K / 18.670K--

Unlock Free Earnings Estimates

Sonnet BioTherapeutic Earnings Reports

  • Sonnet BioTherapeutic | 10-Q: Q3 2024 Earnings Report

    Aug 14 08:49 ET

  • Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

    Aug 14 08:44 ET

  • Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update

    May 14 17:11 ET

  • Sonnet BioTherapeutic | 10-Q: Q2 2024 Earnings Report

    May 14 16:32 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data